Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
暂无分享,去创建一个
K. Tominaga | Toshio Watanabe | Y. Fujiwara | T. Arakawa | M. Shiba | N. Kamata | H. Yamagami | T. Tanigawa | Y. Hirota | S. Ohfuji | Kenji Watanabe | W. Fukushima | M. Sogawa | K. Maeda | Y. Hagihara